why choose us

First received: December 18, 2023

Clinical Trial: Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Dry Eye Syndromes

Study Type: INTERVENTIONAL


Official Title: Efficacy of a New Nanoemulsion Artificial Tear in Dry Eye Disease Management

Brief Summary: This is a prospective cohort study to compare subjective changes in symptoms using the Ocular Surface Disease Index (OSDI) questionnaire, following the recommended dosage of the new nanoemulsion eye drops (Systane Complete)in mild to moderate dry eye patients, and to investigate objective ocular surface changes using modern clinical instruments during the study period.

Read more